| pubmed-article:18316572 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18316572 | lifeskim:mentions | umls-concept:C0042172 | lld:lifeskim |
| pubmed-article:18316572 | lifeskim:mentions | umls-concept:C0007138 | lld:lifeskim |
| pubmed-article:18316572 | lifeskim:mentions | umls-concept:C1518174 | lld:lifeskim |
| pubmed-article:18316572 | lifeskim:mentions | umls-concept:C0312418 | lld:lifeskim |
| pubmed-article:18316572 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:18316572 | lifeskim:mentions | umls-concept:C1443775 | lld:lifeskim |
| pubmed-article:18316572 | lifeskim:mentions | umls-concept:C0036667 | lld:lifeskim |
| pubmed-article:18316572 | lifeskim:mentions | umls-concept:C1546857 | lld:lifeskim |
| pubmed-article:18316572 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:18316572 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:18316572 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:18316572 | pubmed:dateCreated | 2008-3-4 | lld:pubmed |
| pubmed-article:18316572 | pubmed:abstractText | Epidermal growth factor receptor (EGFR) is an attractive target for the treatment of urothelial carcinoma, but a clinical response can be expected in only a small proportion of patients. The aim of this study was to define molecular markers of response to cetuximab therapy in a panel of urothelial carcinoma cell lines. | lld:pubmed |
| pubmed-article:18316572 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18316572 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316572 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18316572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316572 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18316572 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:18316572 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:McConkeyDavid... | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:AdamLianaL | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:WuXifengX | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:TheodorescuDa... | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:Siefker-Radtk... | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:Bar-EliMenash... | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:DinneyColin... | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:ShraderMariss... | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:MunsellMark... | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:BlackPeter... | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:InamotoTeruoT | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:BrownGordon... | lld:pubmed |
| pubmed-article:18316572 | pubmed:author | pubmed-author:AroraAmeetaA | lld:pubmed |
| pubmed-article:18316572 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18316572 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:18316572 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:18316572 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18316572 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18316572 | pubmed:pagination | 1478-86 | lld:pubmed |
| pubmed-article:18316572 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:meshHeading | pubmed-meshheading:18316572... | lld:pubmed |
| pubmed-article:18316572 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18316572 | pubmed:articleTitle | Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells. | lld:pubmed |
| pubmed-article:18316572 | pubmed:affiliation | Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. | lld:pubmed |
| pubmed-article:18316572 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316572 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316572 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316572 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316572 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316572 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316572 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316572 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316572 | lld:pubmed |
